CIK 0001326110
- Large accelerated filer
ImmunityBio, Inc.
Sign in to watch- Ticker
- IBRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 431979754
- Phone
- +1 844-696-5235
- Business address
- 3530 JOHN HOPKINS COURT, SAN DIEGO, CA, 92121
- Former names
- NantKwest, Inc., Conkwest, Inc., ZelleRx Corp
- 4 Open-market sale Director sold 40,000 shares at an average $7.46 ($298,500)
- 4 Open-market sale Director sold 40,000 shares at an average $7.78 ($311,200)
- 4 Grant or award Director acquired 23,753 shares (grant or award)
- 4 Grant or award Director acquired 23,753 shares (grant or award)
- 4 Grant or award Director acquired 23,753 shares (grant or award)
- 4 Grant or award Director acquired 23,753 shares (grant or award)
- 4 Gift Director gave 12,500 shares (gift)
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,983 shares (to pay taxes)
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 4 Gift Chairman and CEO gave 450,000 shares (gift)
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,717 shares (to pay taxes)
- 4/A Open-market sale Director sold 7,719 shares at $7.50 ($57,893)
- 4 Open-market sale Director sold 6,168 shares at $7.50 ($46,260)
- 4 Open-market sale Director sold 20,000 shares at $7.50 ($150,000)
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,717 shares (to pay taxes)
- 4 Open-market sale President and COO sold 32,000 shares at an average $7.49 ($239,671)
- 4 Shares withheld for taxes President and COO gave up 79,322 shares (to pay taxes)
- 4 Open-market buy Chairman and CEO bought 5,618,326 shares
Page 11 of 13 · 251 filings